Table 2.

Adverse events by group

	Add-on (n=49)		Switch (n=53)
	AE	SAE	AE	SAE
Infections and infestations	4, 8.2%	1, 2.0%	8, 14.8%	0
Gastrointestinal disorders	9, 18.4%	0	0	0
Hepatobiliary disorders	3, 6.1%	0	2, 3.7%	0
Respiratory, thoracic and mediastinal disorders	4, 8.2%	0	0	0
Laboratory test abnormalities	2, 4.1%	0	0	0
Metabolism and nutrition disorders	3, 6.1%	0	0	0
Skin and subcutaneous tissue disorders	2, 4.1%	0	2, 3.7%	0
Injury, poisoning and procedural complications	3, 6.1%	0	1, 1.9%	0
General disorders and administration site conditions	1, 2.0%	0	0	0
Neoplasms benign, malignant, unspecified	1, 2.0%	1, 2.0%	3, 5.6%	0
Eye disorders	1, 2.0%	0	0	0
Musculoskeletal and connective tissue disorders	1, 2.0%	0	0	0
Blood and lymphatic system disorders	1, 2.0%	0	0	0

Values are presented as N, %.

AE, adverse event; SAE, serious adverse event.